St. Jude Medical's AGA Medical Subsidiary Files Patent Infringement Lawsuits Against Occlutech
June 16 2011 - 12:24PM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ), a global medical device
company, today announced that AGA Medical, Inc. (acquired by St.
Jude Medical in November 2010) has filed lawsuits against Occlutech
GmbH and Occlutech U.K. (collectively Occlutech) for patent
infringement. The suits, which involve a total of three patents and
seek injunctive relief and monetary damages, were filed in Germany
and the U.K. at the District Court of Duesseldorf and the High
Court of Justice, Chancery Division, Patents Court,
respectively.
The patent infringement lawsuits allege that products
distributed by Occlutech, namely the companies’ atrial septal
defect (ASD) and patent foramen ovale (PFO) closure/occlusion
devices, infringe on key patents used for the St. Jude Medical
Amplatzer® occlusion device platform. The platform, which is
comprised of nitinol-based occlusion devices and accessories,
offers minimally invasive transcatheter treatments for the safe and
effective closure of structural defects found in a patient’s
heart.
"St. Jude Medical has made significant investments in the
structural heart space,” said Frank Callaghan, president of the St.
Jude Medical Cardiovascular Division. “From clinical research to
important product advancements, AGA Medical and now St. Jude
Medical, has contributed considerably to the success of this
marketplace. St. Jude Medical values the innovations we bring to
the industry and will closely protect our intellectual property so
we can continue to bring leading-edge products to the health care
professionals we serve worldwide.”
AGA Medical has been engaged in litigation against Occlutech
since 2006.
About St. Jude Medical
St. Jude Medical develops medical technology and services that
focus on putting more control into the hands of those who treat
cardiac, neurological and chronic pain patients worldwide. The
company is dedicated to advancing the practice of medicine by
reducing risk wherever possible and contributing to successful
outcomes for every patient. St. Jude Medical is headquartered in
St. Paul, Minn. and has four major focus areas that include:
cardiac rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management's current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company's control
and the risk factors and other cautionary statements described in
the Company's filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company's Annual Report on Form 10-K for the fiscal year ended
January 1, 2011 and Quarterly Report on Form 10-Q for the fiscal
quarter ended April 2, 2011. The Company does not intend to update
these statements and undertakes no duty to any person to provide
any such update under any circumstance.
SJM (NYSE:STJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Jul 2023 to Jul 2024